Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Botnar Research Centre, Institute of Musculoskeletal Sciences, Nuffield Orthopaedic Centre, Oxford, UK.
Br J Sports Med. 2014 Dec;48(22):1620-6. doi: 10.1136/bjsports-2013-093178. Epub 2014 Mar 27.
Glucocorticoid injection (GCI) and surgical rotator cuff repair are two widely used treatments for rotator cuff tendinopathy. Little is known about the way in which medical and surgical treatments affect the human rotator cuff tendon in vivo. We assessed the histological and immunohistochemical effects of these common treatments on the rotator cuff tendon.
Controlled laboratory study.
Supraspinatus tendon biopsies were taken before and after treatment from 12 patients undergoing GCI and 8 patients undergoing surgical rotator cuff repair. All patients were symptomatic and none of the patients undergoing local GCI had full thickness tears of the rotator cuff. The tendon tissue was then analysed using histological techniques and immunohistochemistry.
There was a significant increase in nuclei count and vascularity after rotator cuff repair and not after GCI (both p=0.008). Hypoxia inducible factor 1α (HIF-1α) and cell proliferation were only increased after rotator cuff repair (both p=0.03) and not GCI. The ionotropic N-methyl-d-aspartate receptor 1 (NMDAR1) glutamate receptor was only increased after GCI and not rotator cuff repair (p=0.016). An increase in glutamate was seen in both groups following treatment (both p=0.04), while an increase in the receptor metabotropic glutamate receptor 7 (mGluR7) was only seen after rotator cuff repair (p=0.016).
The increases in cell proliferation, vascularity and HIF-1α after surgical rotator cuff repair appear consistent with a proliferative healing response, and these features are not seen after GCI. The increase in the glutamate receptor NMDAR1 after GCI raises concerns about the potential excitotoxic tendon damage that may result from this common treatment.
糖皮质激素注射(GCI)和手术肩袖修复是两种广泛用于治疗肩袖肌腱病的方法。对于这两种治疗方法如何在体内影响肩袖肌腱,人们知之甚少。我们评估了这些常见治疗方法对肩袖肌腱的组织学和免疫组织化学影响。
对照实验室研究。
从接受 GCI 治疗的 12 例患者和接受手术肩袖修复的 8 例患者中,在治疗前后分别采集肩袖冈上肌腱活检。所有患者均有症状,且接受局部 GCI 治疗的患者均无肩袖全层撕裂。然后使用组织学技术和免疫组织化学对肌腱组织进行分析。
肩袖修复后核计数和血管生成显著增加,而 GCI 后则没有(均 p=0.008)。缺氧诱导因子 1α(HIF-1α)和细胞增殖仅在肩袖修复后增加(均 p=0.03),而 GCI 后则没有。离子型 N-甲基-D-天冬氨酸受体 1(NMDAR1)谷氨酸受体仅在 GCI 后增加,而不在肩袖修复后增加(p=0.016)。治疗后两组的谷氨酸均增加(均 p=0.04),而代谢型谷氨酸受体 7(mGluR7)受体仅在肩袖修复后增加(p=0.016)。
手术肩袖修复后细胞增殖、血管生成和 HIF-1α 的增加似乎与增殖性愈合反应一致,而 GCI 后则没有。GCI 后谷氨酸受体 NMDAR1 的增加引起了人们对这种常见治疗方法可能导致的潜在兴奋毒性肌腱损伤的关注。